Get research updatesAttention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
Psychological Treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) - Pilot Evaluation of a New Treatment Manual Based on CBT and DBT
This study has finished and is no longer accepting participants.
In Stockholm
This study has finished and is no longer accepting participants.
In Boston
Researchers compared Mixed salts of a single-entity amphetamine (ADDERALL XR) and placebo to find out how the approaches affected ADHD symptoms in young people with ADHD.
This study has finished and is no longer accepting participants.
In New YorkThis study evaluates the safety and effectiveness of SPD489 for people with ADHD.
This study was withdrawn before enrollment.
Multiple locations, including Little RockThis study evaluated the safety and effectiveness of SPD489 for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study evaluated the safety and effectiveness of LDX for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study evaluated the safety of Metadoxine extended release for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including HaifaThis study evaluated the safety and effectiveness of V81444 for people with ADHD.
This study has finished and is no longer accepting participants.
In Kansas CityResearchers compared SPD503 (Guanfacine hydrochloride) and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixA Pilot Study of Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified
This study has finished and is no longer accepting participants.
In CambridgeSensitivity of Children With Attention Deficit/Hyperactivity Disorder to Memory Error Production
This study has finished and is no longer accepting participants.
Multiple locations, including AngersAn 8 Week, Open-Label Study to Characterize the Response to Modafinil (85 mg Film Coated Tablet) Treatment at Dosages Up to 425 mg/Day in Children and Adolescents With Attention Deficit/Hyperactivity Disorder (ADHD) (With an Open Ended Extension Period)
This study has finished and is no longer accepting participants.
Multiple locations, including ScottsdaleWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.